IBD research history about IBD studies available

Study #1 Oral Inflabloc Cap -- Clinical trial in patients with moderately active Crohn's disease

Date Posted: 2005-03-10

The purpose of this research study is to determine if the oral, investigational drug Inflabloc Cap can safely and effectively reduce the signs and symptoms of moderately active Crohn's disease.
About Inflabloc Cap
Inflabloc Cap contains dehydroepiandrosterone, also known as DHEA. DHEA reduces the production of various substances that cause inflammation. An animal model has shown that DHEA reduces inflammation in the bowel. Inflabloc Cap is a capsule taken orally twice daily.

Principle Investigator:
Atilla Ertan, MD

Study Coordinator:
Inci Ertan, PHD
713-794-0001
ieertan@tmh.tmc.edu
Fax: 713-793-7661

Site Address:
6560 Fannin Street
Suite 2208
Houston, Texas 77030 United States

http://www.ccfa.org/trials/?rm=display_trial¢er_id=1208&doAnchors=1